KAMALIKA PIERIS Theater enthusiasts in the newly independent states of South Asia were finding it difficult, if not impossible, to move away from the proscenium arch” theatre introduced by the western ...
Research analysts at StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report issued on Thursday. The firm set a “hold” rating on the ...
Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...
(Pieris). The combined company will operate under the name Palvella Therapeutics, Inc., and its shares are expected to begin trading on the Nasdaq Capital Market on December 16, 2024, under the ...